FDA proposed OTC label reg would require "extensive" relabeling for cosmetic-drugs -- CTFA.
This article was originally published in The Rose Sheet
Executive Summary
FDA OTC DRUG LABELING REG WOULD REQUIRE "MOST EXTENSIVE" RELABELING EFFORT for the cosmetics industry in "recent memory," the Cosmetic, Fragrance and Toiletry Association said in an April 17 letter to FDA requesting a 120-day extension on the comment period for the proposed rule. The labeling reg "will affect every cosmetic-drug brand and every size of the product type sold in the United States," CTFA maintains.